Home  »  News   »  Company’s Banking Stock: Dissecting a 21.61% Qua...

Company’s Banking Stock: Dissecting a 21.61% Quarterly Revenue Decline Amid Growth

Arcus Biosciences Inc. (RCUS) current stock price is $22.06. During the last trading session, the stock soared, reaching $18.00 after opening at $18.00. The stock’s lowest point was $16.91 before it closed at $17.50.

Arcus Biosciences Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $36.13 on 12/02/22, with the lowest value being $15.70 on 03/10/23.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


52-week price history of RCUS Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Arcus Biosciences Inc.’s current trading price is -38.94% away from its 52-week high, while its distance from the 52-week low is 40.51%. The stock’s price range for this period has remained between $15.70 and $36.13. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.51 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.98 million over the last three months.

Financial Performance and Market Capitalization

Arcus Biosciences Inc. (RCUS) has experienced a quarterly rise of 21.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.23B and boasts a workforce of 500 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 18.85, with a change in price of +1.82. Similarly, Arcus Biosciences Inc. recorded 1,008,170 in trading volume during the last 100 days, posting a change of +9.01%.

RCUS Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RCUS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

RCUS Stock Stochastic Average

As of today, the raw stochastic average of Arcus Biosciences Inc. over the last 50 days is at 92.69%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 91.41%. Further, the company’s Stochastic %K and %D values for the last 20 days were 46.08% and 34.24%, respectively.

RCUS Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded an increase of 6.67%. However, over the last six months, the performance has been stronger by -18.81%. The price of RCUS increased 25.99% over the last 30 days. And in the last five days, it has surged by 20.74%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts